Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Gijsen

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
International Journal of Antimicrobial Agents|March 30, 2021
Letter to the Editor regarding: Ceftriaxone exposure in patients undergoing extracorporeal membrane oxygenationMatthias Gijsen, Pieter Annaert, Kiran Shekar, et al.
Microorganisms|July 2, 2021
Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort AnalysisMatthias Gijsen, Erwin Dreesen, Pieter Annaert, et al.
Infection|February 2, 2024
Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature reviewDorian Vanneste, Matthias Gijsen, Johan Maertens, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort StudyMatthias Gijsen, Erwin Dreesen, Ruth Van Daele, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2020
Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood samplingMatthias Gijsen, Johan Maertens, Katrien Lagrou, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Meropenem Stability in Human Plasma at -20 °C: Detailed Assessment of DegradationMatthias Gijsen, Benjamin Filtjens, Pieter Annaert, et al.
Journal of Clinical Pharmacy and Therapeutics|May 8, 2018
Reliability of serum creatinine-based formulae estimating renal function in non-critically ill surgery patients: Focus on augmented renal clearancePeter Declercq, Matthias Gijsen, Björn Meijers, et al.
International Journal of Antimicrobial Agents|September 29, 2024
Physiologically-based pharmacokinetic modelling in sepsis: A tool to elucidate how pathophysiology affects meropenem pharmacokineticsSalma M Bahnasawy, Neil J Parrott, Matthias Gijsen, et al.
Anaesthesiology Intensive Therapy|July 21, 2021
Reproducibility of fluid status measured by bioelectrical impedance analysis in healthy volunteers: a key requirement to monitor fluid status in the intensive care unitMatthias Gijsen, Eline Simons, Pieter De Cock, et al.
The Journal of Antimicrobial Chemotherapy|July 11, 2022
Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumoniaErwin Dreesen, Matthias Gijsen, Omar Elkayal, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
International Journal of Antimicrobial Agents|March 30, 2021
Letter to the Editor regarding: Ceftriaxone exposure in patients undergoing extracorporeal membrane oxygenationMatthias Gijsen, Pieter Annaert, Kiran Shekar, et al.
Microorganisms|July 2, 2021
Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients Are Not Affected by Extracorporeal Membrane Oxygenation: A Matched Cohort AnalysisMatthias Gijsen, Erwin Dreesen, Pieter Annaert, et al.
Infection|February 2, 2024
Ceftazidime-related neurotoxicity in a patient with renal impairment: a case report and literature reviewDorian Vanneste, Matthias Gijsen, Johan Maertens, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort StudyMatthias Gijsen, Erwin Dreesen, Ruth Van Daele, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 16, 2020
Cefepime therapeutic drug monitoring: Evaluation of agreement between peripheral and central venous blood samplingMatthias Gijsen, Johan Maertens, Katrien Lagrou, et al.
Antibiotics (Basel, Switzerland)|April 30, 2021
Meropenem Stability in Human Plasma at -20 °C: Detailed Assessment of DegradationMatthias Gijsen, Benjamin Filtjens, Pieter Annaert, et al.
Journal of Clinical Pharmacy and Therapeutics|May 8, 2018
Reliability of serum creatinine-based formulae estimating renal function in non-critically ill surgery patients: Focus on augmented renal clearancePeter Declercq, Matthias Gijsen, Björn Meijers, et al.
International Journal of Antimicrobial Agents|September 29, 2024
Physiologically-based pharmacokinetic modelling in sepsis: A tool to elucidate how pathophysiology affects meropenem pharmacokineticsSalma M Bahnasawy, Neil J Parrott, Matthias Gijsen, et al.
Anaesthesiology Intensive Therapy|July 21, 2021
Reproducibility of fluid status measured by bioelectrical impedance analysis in healthy volunteers: a key requirement to monitor fluid status in the intensive care unitMatthias Gijsen, Eline Simons, Pieter De Cock, et al.
The Journal of Antimicrobial Chemotherapy|July 11, 2022
Ceftriaxone dosing based on the predicted probability of augmented renal clearance in critically ill patients with pneumoniaErwin Dreesen, Matthias Gijsen, Omar Elkayal, et al.
Pageof 5